Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
Trop Gastroenterol
; 20(3): 116-9, 1999.
Article
em En
| MEDLINE
| ID: mdl-10695417
ABSTRACT
AIMS:
Diabetic gastroparesis is a common complication seen in 20-50% of patients due to autonomic neuropathy involving vagal supply. Cisapride, a specific gastrointestinal cholinomimetic agent may thus be effective.METHODS:
Fifty-one diabetic patients (age 12-65 years) of disease duration > 5 years were assessed for symptomatic gastroparesis, other diabetic complications and glycemic control. Gastric emptying time (GET) was estimated using a solid meal method (99mTc labeled rice based idli) and patients randomized to receive either cisapride or placebo for a period of 2 weeks. Cisapride was administered in a dose of 10 mg TID. GET and symptom scores were reassessed on the therapy after 2 weeks.RESULTS:
Twenty nine of 51 (56.8%) patients had gastroparesis. Mean GET in the gastroparesis group was 141 +/- 66 minutes compared to 24.53 +/- 10 minutes in the non gastroparesis group (p < 0.01). GET decreased by 72% amongst the patients who received cisapride compared to 23% in the placebo group (p < 0.001). Symptom scores also improved in the cisapride group; no adverse effects were noted.CONCLUSIONS:
Cisapride improves the symptom score and the solid gastric emptying time in patients suffering from diabetic gastroparesis.
Buscar no Google
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Fármacos Gastrointestinais
/
Gastroparesia
/
Cisaprida
/
Neuropatias Diabéticas
/
Esvaziamento Gástrico
Tipo de estudo:
Clinical_trials
/
Etiology_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Child
/
Humans
/
Middle aged
Idioma:
En
Revista:
Trop Gastroenterol
Ano de publicação:
1999
Tipo de documento:
Article